DHR

Danaher Stock Price

182.41
0.00 (0.0%)
182.41
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Danaher Corporation DHR NYSE Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-1.26 -0.69% 182.41 181.98 186.6899 184.41 183.67 16:03:48
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
26,943 2,130,185 $ 184.88 $ 393,821,019 2,623,555 119.60 - 187.19
Last Trade Time Type Quantity Stock Price Currency
16:15:53 1 $ 182.41 USD

Danaher Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 128.97B 707.02M 627.47M $ 17.91B $ 3.72B 4.05 42.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
6.74M $ 0.68 0.37% - -

more financials information »

Danaher News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical DHR Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week182.00187.19181.41183.662,165,6450.410.23%
1 Month166.78187.19166.13176.552,360,41015.639.37%
3 Months155.98187.19151.365166.943,036,24026.4316.94%
6 Months158.45187.19119.60154.243,338,04923.9615.12%
1 Year140.38187.19119.60149.515,005,17242.0329.94%
3 Years83.26187.1978.97128.833,160,41999.15119.08%
5 Years87.17187.199.52113.612,945,55095.24109.26%

Danaher Description

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in four segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which adds to its life sciences segment.


Your Recent History
NYSE
DHR
Danaher
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.